Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Hungary Life Sciences, Biotech & Healthcare Investment Conference

22 Jan 2014 - 22 Jan 2014 - Budapest, Hungary



Bookmark and Share


A not-to-be-missed event showcasing Hungary’s achievements as the most innovative pharmaceutical and healthcare hub in CEE and beyond. 

Get the first -hand information from the relevant industry professionals and assess the market potential.

The proposed conference is part of our Healthcare series of events dedicated to the Central European pharmaceutical and medical markets. Following the successful events concluded in Russia, Kazakhstan, Poland, Romania, Georgia, Azerbaijan and Ukraine, it is now Hungary’s turn to be showcased. Hungary’s life sciences and medical technology industry is well-developed and has been granted international recognition. Innovative SMEs are continuously growing in numbers and strength, while foreign med tech producers have indentified Hungary as an attractive investment destination, offering a highly productive workforce. Featuring one of the largest and most developed drug markets in CEE, Hungary ranks n°1 in the region for FDI in the pharmaceutical sector. Investors will find several fast-growing and renowned R&D institutions and the country has the highest number of biotech companies in the region and keeps attracting new ones. Registration process is open for delegates and we currently offer an early bird discount.


Further information
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!